FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Lotvin Alan 2. Issuer Name and Ticker or Trading Symbol CVS HEALTH Corp [ CVS ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
EVP&President-PharmacyServices
(Last)         (First)         (Middle)
ONE CVS DRIVE
3. Date of Earliest Transaction (MM/DD/YYYY)
6/28/2021
(Street)
WOONSOCKET, RI 02895
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  6/28/2021    S(1)    2781  D $83.67  61047.6756  D   
Common Stock                 492  I  By Children's Trusts 
Common Stock (restricted)                 6027  D   
Stock Unit                 29505.3163  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock Credits  $1.00                   (2)  (3) Common Stock  556.7643    556.7643  D   
Stock Option  $102.26                  4/1/2016 (4) 4/1/2022  Common Stock  21386    21386  D   
Stock Option  $104.82                  4/1/2017 (5) 4/1/2023  Common Stock  27395    27395  D   
Stock Option  $78.05                  4/3/2018 (6) 4/3/2024  Common Stock  32911    32911  D   
Stock Option  $62.21                  4/1/2019 (7) 4/1/2025  Common Stock  22541    22541  D   
Stock Option  $54.19                  4/1/2020 (8) 4/1/2029  Common Stock  70702    70702  D   
Stock Option  $58.34 (9)                 4/1/2021 (10) 4/1/2030  Common Stock  140797    140797  D   
Stock Option  $74.30                  4/1/2022 (11) 4/1/2031  Common Stock  120940    120940  D   

Explanation of Responses:
(1)  All sales were effected pursuant to a Rule 10b5-1 plan.
(2)  Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
(3)  Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
(4)  Option became exercisable in four equal annual installments, commencing 4/1/2016.
(5)  Option became exercisable in four equal annual installments, commencing 4/1/2017.
(6)  Option became exercisable in four equal annual installments, commencing 4/3/2018.
(7)  Option became exercisable in four equal annual installments, commencing 4/1/2019.
(8)  Option became exercisable in four equal annual installments, commencing 4/1/2020.
(9)  The number of shares subject to the option were calculated using a 30-day average price.
(10)  Option became exercisable in four equal annual installments, commencing 4/1/2021.
(11)  Option becomes exercisable in four equal annual installments, commencing 4/1/2022.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Lotvin Alan
ONE CVS DRIVE
WOONSOCKET, RI 02895


EVP&President-PharmacyServices

Signatures
/s/ Alan M. Lotvin 6/29/2021
**Signature of Reporting Person Date
CVS Health (NYSE:CVS)
Historical Stock Chart
From Aug 2021 to Sep 2021 Click Here for more CVS Health Charts.
CVS Health (NYSE:CVS)
Historical Stock Chart
From Sep 2020 to Sep 2021 Click Here for more CVS Health Charts.